Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imaging
VEGFI-associated CTRCD is frequent and occurs early. This finding has implications for prioritising early cardiac imaging follow-up after commencing treatment. Underlying mechanisms include myocardial and microvascular effects that are at least partly independent of hypertension.
Authors
- Ninian N. Lang (ORCID: https://orcid.org/0000-0001-8441-6887)
- Giles Roditi (ORCID: https://orcid.org/0000-0001-9393-7764)
- Piotr Sonecki
- Katriona Brooksbank (ORCID: https://orcid.org/0000-0002-9129-1717)
- Rhian M. Touyz (ORCID: https://orcid.org/0000-0003-0670-0887)
- Paul I. Welsh (ORCID: https://orcid.org/0000-0002-7970-3643)
- Jeff White (ORCID: https://orcid.org/0000-0002-0277-5921)
- Susmita Basak
- Robert J. Jones (ORCID: https://orcid.org/0000-0002-2904-6980)
- Kenneth Mangion (ORCID: https://orcid.org/0000-0002-3505-7440)
- J. Grimley Evans
- Stephen J.H. Dobbin (ORCID: https://orcid.org/0000-0002-9111-0242)
- John McClure (ORCID: https://orcid.org/0000-0003-4839-5462)
- Colin Berry (ORCID: https://orcid.org/0000-0002-4547-8636)
- Steven Sourbron (ORCID: https://orcid.org/0000-0002-3374-3973)
- Balaji Venugopal
- Elaine Butler
- Mark C Petrie
Institutions
- Glasgow Royal Infirmary (GB)
- McGill University Health Centre (CA)
- Golden Jubilee National Hospital (GB)
- UK Research and Innovation (GB)
- Queen Elizabeth University Hospital (GB)
- University of Glasgow (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- Heart
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1136/heartjnl-2024-325535
- Citations
- 2
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- British Heart Foundation